Back
Haemonetics Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Buy
86
HAE
Haemonetics
Last Price:
90.82
Seasonality Move:
4.35%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Haemonetics Price Quote
$90.82
-0.96 (-1.05%)
(Updated: November 14, 2024 at 5:55 PM ET)
Haemonetics Key Stats
Buy
86
Haemonetics (HAE)
is a Buy
Day range:
$91.45 - $93.97
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
40.78
P/S ratio:
3.53
P/B ratio:
5.34%
Volume:
773.2K
Avg. volume:
619.8K
1-year change:
5.9%
Market cap:
$4.7B
Revenue:
$1.3B
EPS:
$2.41
How Much Does Haemonetics Make?
-
How Much Are Haemonetics's Sales Annually?
HAE Revenues are $1.3B -
How Much Profit Does Haemonetics's Make A Year?
HAE net income is $117.6M
Is Haemonetics Growing As A Company?
-
What Is Haemonetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is Haemonetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.38%
Haemonetics Stock Price Performance
-
Did Haemonetics Stock Go Up Last Month?
Haemonetics share price went up by 22.42% last month -
Did HAE's Share Price Rise Over The Last Year?
HAE share price rose by 5.9% over the past 1 year
What Is Haemonetics 52-Week High & Low?
-
What Is Haemonetics’s 52-Week High Share Price?
Haemonetics has traded as high as $97.97 over the past 52 weeks -
What Is Haemonetics’s 52-Week Low Share Price?
Haemonetics has traded as low as $70.25 over the past 52 weeks
Haemonetics Price To Free Cash Flow
-
Is Haemonetics Stock Overvalued?
Haemonetics is trading at a price to free cash flow ratio of 235.90 -
Is Haemonetics Stock Undervalued?
Haemonetics EV to Free Cash Flow ratio is 275.92 -
What Is Haemonetics’s Price Earnings Growth Ratio?
HAE PEG ratio is 0.00 -
Is Haemonetics Trading At A Premium To Earnings?
Haemonetics EV to EBIT ratio is 33.55
Is It Risky To Buy Haemonetics?
-
How Much Debt Does Haemonetics Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Haemonetics Have?
Cash and short term investments quarterly total is $299.3M -
What Is Haemonetics’s Book Value Per Share?
Book value per share is 17.44
Is Haemonetics Cash Flow Positive?
-
What Is HAE Cash Flow From Operations?
Cash flow from operations (TTM) is $84.9M -
What Is Haemonetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $304.8M -
What Is Haemonetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$444.6M
Haemonetics Return On Invested Capital
-
Is Management Doing A Good Job?
HAE return on invested capital is 6.54% -
What Is Haemonetics Return On Assets?
ROA measures how assets are converting to revenues and is 5.4% -
What Is HAE Return On Equity?
ROE is a measure of profitability and is 13.51%
Haemonetics Earnings Date & Stock Price
-
What Is Haemonetics's Stock Price Today?
A single share of HAE can be purchased today for 91.78 -
What Is Haemonetics’s Stock Symbol?
Haemonetics trades on the nyse under the ticker symbol: HAE -
When Is Haemonetics’s Next Earnings Date?
The next quarterly earnings date for Haemonetics is scheduled on February 7, 2025 -
When Is HAE's next ex-dividend date?
Haemonetics's next ex-dividend date is November 15, 2024 -
How To Buy Haemonetics Stock?
You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Haemonetics Competitors
-
Who Are Haemonetics's Competitors?
Below is a list of companies who compete with Haemonetics or are related in some way:
Haemonetics Dividend Yield
-
What Is HAE Dividend Yield?
Haemonetics’s dividend yield currently is 0% -
What Is Haemonetics’s Payout Ratio?
Haemonetics’s payout ratio is 0% -
When Did Haemonetics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Haemonetics’s Dividend Per Share?
Haemonetics pays a dividend of $0.00 per share
Haemonetics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 37.5% | 4.39% |
| Revenue: | 8.59% | 0.86% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 110.80 |
| Upside from Last Price: | 20.72% |